Skip to main content
. 2023 Jun 26;78(10):1237–1248. doi: 10.1111/anae.16070

Table 3.

Opioid‐related adverse drug events (ORADEs) in the modified‐ and immediate‐release opioid group or the immediate‐release opioid only matched groups. Values are number (proportion).

Outcome MR ± IR opioids IR opioids only p value
n = 347 n = 347
Total all ORADEs 71 (20.5%) 44 (12.7%) 0.008
Total gastro‐intestinal ORADEs 37 (10.7%) 15 (4.3%) 0.002
Constipation 20 (5.8%) 6 (1.7%) 0.008
Nausea and vomiting 16 (4.6%) 8 (2.3%) 0.144
Heartburn 1 (0.3%) 1 (0.3%) 1.000
Diarrhoea 0 0 N/A
Abdominal pain 1 (0.3%) 0 1.000
Other gastro‐intestinal ORADEs 0 1 (0.3%) 1.000
Total central nervous system ORADEs 13 (3.7%) 8 (2.3%) 0.376
Somnolence 3 (0.9%) 0 0.249
Delirium a 7 (2%) 6 (1.7%) 1.000
Dizziness 2 (0.6%) 2 (0.6%) 1.000
Headache 1 (0.3%) 1 (0.3%) 1.000
Hallucinations 0 0 N/A
Sleep disturbance 1 (0.3%) 0 1.000
Other central nervous system ORADEs 0 0 N/A
Respiratory depression 9 (2.6%) 8 (2.3%) 1.000
Urinary retention 14 (4%) 15 (4.3%) 1.000
Other ORADEs (total) 7 (2.0%) 3 (0.9%) 0.340
Pruritis 1 (0.3%) 2 (0.6%) 1.000
Dry mouth 1 (0.3%) 0 1.000
Opioid toxicity 0 0 N/A
In‐hospital fall 6 (1.7%) 0 0.031
Muscle spasm 0 1 (0.3%) 1.000

N/A, not applicable.

a

Not due to infective sources or substance withdrawal.